TSX open
Loading markets…

Advertisement

Stocks/TSX-V/NRX

NurExone Biologic Inc. (NRX : TSX-V)

Common Stock

$0.54

CAD

-0.01 (-1.82%)

Last updated: 2026-10-23

Follow NRX

NRX

NurExone Biologic Inc.

Source:WealthAwesomeWealthAwesome
↓ $0.11 (-16.92%)
30 day period
$0.54$0.61$0.69Sep 11Oct 2Oct 23

Performance

1 Day

-1.82%

1 Week

-10.00%

1 Month

-12.90%

YTD

-16.92%

Key Statistics

Market Cap

$49.70M

52W High

$0.76

52W Low

$0.43

P/E Ratio

-

50 Day MA

$0.60

200 Day MA

$0.60

Beta

0.33

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
10/23/2026$0.53$0.54$0.53$0.54$0.543,500
10/22/2026$0.55$0.55$0.55$0.55$0.556,001
10/21/2026$0.55$0.55$0.54$0.54$0.5417,000
10/20/2026$0.58$0.58$0.54$0.54$0.5416,000
10/19/2026$0.61$0.61$0.55$0.55$0.5515,000
10/16/2026$0.62$0.62$0.60$0.60$0.6010,015
10/15/2026$0.60$0.60$0.60$0.60$0.60500
10/14/2026$0.60$0.60$0.58$0.58$0.587,000
10/13/2026$0.62$0.62$0.60$0.60$0.604,001
10/9/2026$0.60$0.60$0.60$0.60$0.6012,009

Analyst Price Targets

Based on analyst covering NRX · as of Sep 17, 2026

📈

Wall Street analysts forecast NRX stock price to rise 361.4% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$2.49

+361.4% Upside

Current Price

C$0.54

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on NRX's historical volatility

HistoricalForecast68%95%
C$0.19C$0.59C$0.99C$1.39C$1.79C$2.19TodayJun 11Aug 20Oct 23Dec 5Jan 18Mar 2

30-Day Vol

99.7%

Annualized

90-Day Vol

89.8%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$0.65

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.57C$0.41 – C$0.81
60 trading daysC$0.61C$0.37 – C$0.99
90 trading daysC$0.65C$0.36 – C$1.17

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About NurExone Biologic Inc.

NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It offers ExoPTEN, for treatment of acute spinal cord injuries. The company was founded in 2020 and is based in Toronto, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-6.05M
Profit Margin
0.00%
ROE (TTM)
-450.96%
EPS (Diluted)
-0.11
Book Value
0.02

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About NRX

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
GRIGalore Resources Inc$0.02+100.00%
PWROPower One Resources Corp.$0.03+66.67%
PCQPetrolympic Ltd$0.17+61.90%
JADEJade Leader Corp$0.02+33.33%
NKW-HOceanic Wind Energy Inc.$0.13+31.58%
YAYTHS Maple Holdings Ltd.$0.13+30.00%
GSSGossan Resources Ltd$0.04+28.57%
AKH-HAlaska Hydro Corporation$0.03+25.00%

NRX.V news timeline

8 articles covering NRX.V, most recent first

Latest

Why NurExone Biologic Inc. stock is plummeting today

•Stocks

Advertisement